Table 1.
3D echocardiographic parameters measured by the two operators in the reproducibility analysis.
| Operator 1 | Operator 2 | ||
|---|---|---|---|
| 1st measurements | 2nd measurements | ||
| 3D RV EDV, mL | 167.5 ± 63.1 | 174.2 ± 66.3 | 183.2 ± 64.3 |
| 3D RV ESV, mL | 95.4 ± 55.7 | 98.4 ± 60.6 | 99.8 ± 56.2 |
| LESV, mL | 134.2 ± 58.6 | 140.8 ± 63.5 | 144.9 ± 60.5 |
| RESV, mL | 131.2 ± 55.2 | 135.3 ± 59.5 | 143.4 ± 58.4 |
| AESV, mL | 130.9 ± 62.8 | 135.9 ± 66.7 | 141.0 ± 62.9 |
| 3D RV GLS, % | −17.6 ± 7.1 | −18.5 ± 7.9 | −18.4 ± 7.5 |
| 3D RV GCS, % | −19.5 ± 9.0 | −20.7 ± 9.4 | −19.4 ± 7.5 |
| 3D RV GAS, % | −31.6 ± 12.2 | −32.8 ± 13.2 | −33.2 ± 12.1 |
| Outflow tract EDV, mL | 47.9 ± 19.0 | 51.5 ± 21.0 | 55.9 ± 20.4 |
| Outflow tract ESV, mL | 29.5 ± 15.9 | 31.6 ± 18.3 | 31.8 ± 17.1 |
| Inflow tract EDV, mL | 33.9 ± 12.5 | 35.2 ± 13.7 | 34.4 ± 12.8 |
| Inflow tract ESV, mL | 22.8 ± 11.2 | 24.5 ± 13.3 | 22.9 ± 12.8 |
| FW basal anterior EDV, mL | 14.3 ± 7.4 | 14.5 ± 6.5 | 16.0 ± 6.3 |
| FW basal anterior ESV, mL | 7.1 ± 5.6 | 6.8 ± 5.3 | 7.3 ± 4.7 |
| FW basal lateral EDV, mL | 11.7 ± 5.0 | 11.7 ± 4.5 | 12.3 ± 4.4 |
| FW basal lateral ESV, mL | 5.3 ± 4.0 | 5.2 ± 3.9 | 5.5 ± 3.6 |
| FW basal posterior EDV, mL | 8.5 ± 3.9 | 8.5 ± 4.0 | 8.4 ± 3.5 |
| FW basal posterior ESV, mL | 4.5 ± 3.2 | 4.5 ± 3.4 | 4.6 ± 3.2 |
| Sept. basal posterior EDV, mL | 8.3 ± 3.4 | 8.5 ± 3.2 | 9.2 ± 3.3 |
| Sept. basal posterior ESV, mL | 4.4 ± 3.0 | 4.2 ± 2.9 | 4.5 ± 2.7 |
| Sept. basal anterior EDV, mL | 6.5 ± 2.8 | 6.6 ± 2.7 | 6.7 ± 2.6 |
| Sept. basal anterior ESV, mL | 3.6 ± 2.4 | 3.6 ± 2.4 | 3.7 ± 2.3 |
| FW mid anterior EDV, mL | 8.5 ± 4.5 | 8.8 ± 4.2 | 9.8 ± 4.3 |
| FW mid anterior ESV, mL | 4.1 ± 3.4 | 3.8 ± 3.2 | 4.3 ± 2.9 |
| FW mid lateral EDV, mL | 7.3 ± 3.1 | 7.4 ± 3.0 | 7.9 ± 3.2 |
| FW mid lateral ESV, mL | 3.2 ± 2.3 | 3.1 ± 2.3 | 3.4 ± 2.2 |
| FW mid posterior EDV, mL | 3.8 ± 1.7 | 3.8 ± 1.7 | 3.8 ± 1.8 |
| FW mid posterior ESV, mL | 1.9 ± 1.3 | 1.9 ± 1.4 | 1.9 ± 1.4 |
| Sept. mid posterior EDV, mL | 5.2 ± 2.2 | 5.4 ± 2.3 | 5.8 ± 2.5 |
| Sept. mid posterior ESV, mL | 2.7 ± 1.9 | 2.7 ± 1.9 | 2.9 ± 1.8 |
| Sept. mid anterior EDV, mL | 3.5 ± 1.4 | 3.6 ± 1.4 | 3.7 ± 1.5 |
| Sept. mid anterior ESV, mL | 1.9 ± 1.3 | 1.9 ± 1.2 | 2.0 ± 1.2 |
| FW apical anterior EDV, mL | 2.1 ± 1.3 | 2.2 ± 1.3 | 2.5 ± 1.4 |
| FW apical anterior ESV, mL | 1.1 ± 1.0 | 1.1 ± 1.1 | 1.2 ± 1.0 |
| FW apical posterior EDV, mL | 1.1 ± 0.6 | 1.1 ± 0.5 | 1.2 ± 0.7 |
| FW apical posterior ESV, mL | 0.5 ± 0.4 | 0.5 ± 0.4 | 0.6 ± 0.4 |
| Apex EDV, mL | 5.1 ± 2.5 | 5.2 ± 2.3 | 5.5 ± 2.8 |
| Apex ESV, mL | 3.0 ± 2.1 | 2.9 ± 2.1 | 3.2 ± 2.2 |
Cell values are mean ± standard deviation.
AESV, anteroposterior end-systolic volume; EDV, end-diastolic volume; ESV, end-systolic volume; FW, free wall; GAS, global area strain; GCS, global circumferential strain; GLS, global longitudinal strain; LESV, longitudinal end-systolic volume; RESV, radial end-systolic volume; RV, right ventricular; Sept., septum.